Mizunuma H, Obara M, Yamada K, Ibuki Y
Department of Obstetrics and Gynecology, Gunma University School of Medicine, Maebashi.
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Mar;42(3):253-8.
Using pulsatile LH-RH administration, ovulation induction was performed in women with pituitary dwarfism (PD, n = 1), isolated gonadotropin deficiency (IGD, n = 5), secondary hypothalamic amenorrhea (gestagen negative (AM2, n = 10), positive (AM1, n = 5)), polycystic ovarian disease (PCO, n = 6) and anovulatory cycle (ANOV, n = 1). Five to 20 micrograms of LH-RH was administered subcutaneously with a pulse frequency of 90 min to 2 h, in 76 treatment cycles. The ovulation rate of IGD, AM2, AM1 and PCO was 54.5, 83.3, 12.5 and 50.0%, respectively, all being significantly different from each other. In some cases, ovulation induction was repeated for several cycles without any interruption, and chronic effects of this therapy on the subsequent cycle were examined. In IGD and AM2, subsequent cycles were well stimulated, while those of PCO became refractory. These results indicate that pulsatile LH-RH administration should be the first choice of ovulation induction in IGD and AM2, and less effective in AM1 and PD. When this treatment is applied for PCO, the luteal phase should be supported by alternative methods to avoid pituitary desensitization.
采用脉冲式促黄体生成素释放激素(LH-RH)给药,对垂体性侏儒症(PD,n = 1)、孤立性促性腺激素缺乏症(IGD,n = 5)、继发性下丘脑闭经(孕激素阴性(AM2,n = 10)、阳性(AM1,n = 5))、多囊卵巢疾病(PCO,n = 6)和无排卵周期(ANOV,n = 1)的女性进行排卵诱导。在76个治疗周期中,以90分钟至2小时的脉冲频率皮下注射5至20微克LH-RH。IGD、AM2、AM1和PCO的排卵率分别为54.5%、83.3%、12.5%和50.0%,彼此之间均有显著差异。在某些情况下,排卵诱导连续进行了几个周期而无任何中断,并检查了该疗法对后续周期的长期影响。在IGD和AM2中,后续周期受到良好刺激,而PCO的周期则变得难治。这些结果表明,脉冲式LH-RH给药应作为IGD和AM2排卵诱导的首选方法,而在AM1和PD中效果较差。当将此治疗应用于PCO时,应采用替代方法支持黄体期,以避免垂体脱敏。